This paper has been accepted and is currently in production.
It will appear shortly on 10.2196/105768
The final accepted version (not copyedited yet) is in this tab.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Repeated Exposure: Baseline Symptom Severity Moderates the Efficacy of Virtual Reality (VR) Compassion Training: Secondary Analysis of a Sequentially-Allocated Controlled Trial
ABSTRACT
Background:
Virtual Reality (VR) is increasingly utilised for delivering compassion-focused interventions. However, existing research often aggregates data from minimal and elevated symptomatic samples, potentially masking distinct symptom trajectories and obscuring how individuals with varying levels of baseline distress respond to highly immersive therapeutic environments.
Objective:
This study investigated whether baseline symptom severity moderates the efficacy of a VR self-compassion training paradigm, aiming to determine if distinct recovery trajectories emerge between minimal and elevated distress cohorts.
Methods:
We conducted a secondary analysis of a sequentially-allocated controlled trial. Participants (N = 65) were classified into “Minimal” (n = 31) or “Elevated” (n = 34) distress groups based on baseline Depression and Anxiety scores on the DASS-21. All participants completed two sessions of an immersive VR self-compassion intervention. Symptom trajectories (Depression and Anxiety) were analysed across four timepoints using mixed ANOVAs to evaluate immediate and inter-session symptom responses.
Results:
Anxiety decreased significantly across both the minimal and elevated groups, indicating a robust, transdiagnostic soothing effect (main effect of Time: p = .009). For depression, the elevated group displayed a theoretically predicted non-linear trajectory of initial reduction followed by inter-session recurrence, though the Time x Symptom Status interaction was marginally significant (p = .058). The clinical impact of the intervention was substantial; following the second session, 44.1% (15/34) of the elevated distress cohort successfully reached minimal symptom levels.
Conclusions:
VR functions as a robust safety signal for rapidly down-regulating threat arousal and anxiety, irrespective of baseline severity. Conversely, the volatile response observed in depression aligns with theoretical cognitive resistance to compassion. These findings highlight the necessity of multi-session VR protocols for individuals with elevated pathology to effectively integrate the physiological activation of the soothing system and overcome cognitive blocks. Clinical Trial: N/A
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.